Bioactivity:

PI3K-IN-2 is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in

CAS nr:

1225037-39-7

Purity:

98%

Molecular Weight:

411,38

SMILES:

C1COCCN1c1nc(c2cnc(cc2C(F)(F)F)N)nc(n1)N1CCOCC1

Formula:

C17H20F3N7O2

Pathway:

PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling,Others,MAPK,PI3K/Akt/mTOR signaling

Target:

mTOR,PI3K,Others,S6 Kinase,S6 Kinase